The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecan

Schreiber, AR; O'Bryant, CL; Kabos, P; Diamond, JR

Diamond, JR (通讯作者),Univ Colorado, Div Med Oncol, Anschutz Med Campus,2801 East 17th Ave, Mailstop, Aurora, CO 80045 USA.

EXPERT REVIEW OF ANTICANCER THERAPY, 2023; 23 (10): 1061

Abstract

IntroductionMetastatic triple-negative breast cancer (TNBC) is an aggressive sub-type of breast cancer. Despite recent advances, metastatic TNBC remai......

Full Text Link